Stockscreener 앱 받기
6.51
6.37%
0.39
전일 마감가:
$6.12
열려 있는:
$6.22
하루 거래량:
387.24K
Relative Volume:
1.10
시가총액:
$1.25B
수익:
$9.96M
순이익/손실:
$-199.33M
주가수익비율:
-1.9534
EPS:
-3.3326
순현금흐름:
$-93.38M
1주 성능:
+34.78%
1개월 성능:
+39.70%
6개월 성능:
+96.08%
1년 성능:
+201.39%
1일 변동 폭
$6.22
$6.66
1주일 범위
$5.0501
$6.66
52주 변동 폭
$2.1125
$7.9825
인벤티바 Stock (IVA) Company Profile
IVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
6.51 | 1.17B | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
인벤티바 Stock (IVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 개시 | Leerink Partners | Outperform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-11-06 | 개시 | Wolfe Research | Outperform |
| 2025-09-03 | 재개 | H.C. Wainwright | Buy |
| 2025-08-27 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | TD Cowen | Buy |
| 2024-11-12 | 개시 | UBS | Neutral |
| 2023-10-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-19 | 업그레이드 | Societe Generale | Sell → Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2022-11-15 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2021-03-08 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2020-08-05 | 개시 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | Guggenheim | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
인벤티바 주식(IVA)의 최신 뉴스
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva’s (IVA) “Buy” Rating Reiterated at UBS Group - Defense World
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - Zacks Investment Research
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeHere's Why - MarketBeat
The time has not yet come to remove your chips from the table: Inventiva ADR (IVA) - setenews.com
Debt to assets ratio of Inventiva SA ADR – LSX:A2P796 - TradingView — Track All Markets
Net margin % of Inventiva SA ADR – LSX:A2P796 - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025 - GlobeNewswire Inc.
Weekly Investment Analysts’ Ratings Changes for Inventiva (IVA) - Defense World
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Inventiva (NASDAQ:IVA) Price Target Cut to $11.00 by Analysts at Guggenheim - Defense World
ETFs Investing in Inventiva SA ADR Stocks - TradingView
Form 424B5 Inventiva S.A. - StreetInsider
Its Stock Has Paid Off Big Time For Inventiva ADR - Setenews
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Upgraded at Wolfe Research - Defense World
Assemblée Générale Mixte du 27 novembre 2025 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 461.9% in October - MarketBeat
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Inventiva (NASDAQ:IVA) Raised to “Hold” at Wall Street Zen - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Inventiva Stock Falls 9% Following Announcement of a Dilutive Financing Program - Idéal Investisseur
FY2025 EPS Estimates for Inventiva Cut by HC Wainwright - MarketBeat
Why You Need Galapagos NV ADR (GLPG) On Your Watchlist - fostersleader.com
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Inventiva Stock Price, Quotes and Forecasts | NASDAQ:IVA - Benzinga
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva (IVA) to Release Quarterly Earnings on Thursday - Defense World
인벤티바 (IVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):